Internet, parks, train tracks can affect stroke risk for neighborhoods
People living in neighborhoods with high rates of environmental and socioeconomic problems may face a higher risk for heart disease and...
Source: thegrio.com
Page 6 - Oncology Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oncology Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oncology Program Today - Breaking & Trending Today
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
Clear registration pathway and FDA agreement on the ORALTO Phase 3 trial for MAT2203 represent critical steps forward and supports partnership discussions Continued success of Compassionate/Expanded...
Source: marketscreener.com
FDA Approval Highlights: OncLive's February Recap
In case you missed it, below is a recap of all drugs that have been approved by the FDA in February 2024.
Source: onclive.com
FDA Approves Amtagvi for Pretreated, Advanced Melanoma
The Food and Drug Administration approve Amtagvi, a TIL therapy, for patients with advanced melanoma who had disease progression on or after a checkpoint inhibitor and targeted therapy.
Source: curetoday.com
Dr Wainberg on the FDA Approval of NALIRIFOX in mPDAC
Zev A. Wainberg, MD, discusses the FDA approval of NALIRIFOX for patients with metastatic pancreatic ductal adenocarcinoma.
Source: onclive.com